Ukrainian partner of China’s Sinovac applies for COVID-19 vaccine registration
Ukrainian pharmaceutical company Lekhim said on Tuesday it had submitted documents to the Ukrainian authorities to register China's Sinovac COVID-19 vaccine.
Lekhim, a partner of Sinovac Biotech, has signed an agreement with China's leading vaccine manufacturer to deliver 5 million doses in Ukraine, including 1.9 million via state procurement, in the first half of 2021. But it must obtain state registration in Ukraine before starting the shipment.
ALSO READ
-
East Asia’s AI Boom Fuels Growth and Opens a New Path to Better Jobs
-
More Than Shorter Commute: How Compact Cities Can Help Migrant Workers Find Jobs
-
ILO Report Reveals How to Bring Social Security Within Reach of Informal Workers
-
WTO Sets Up Panel on EU Carbon Border Rules as Russia Challenges Restrictions
-
WHO Brings Global Experts Together to Strengthen Herbal Medicine Quality and Safety
Google News